Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Buy
51
SOPH Quote, Financials, Valuation and Earnings
Last price:
$4.65
Seasonality move
:
5.53%
Day range:
$4.56 - $4.75
52-week range:
$2.58 - $5.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.26x
P/B ratio:
5.20x
Volume:
22.8K
Avg. volume:
84.4K
1-year change:
38.39%
Market cap:
$315.5M
Revenue:
$65.2M
EPS (TTM):
-$1.12
Analysts' Opinion
-
Consensus RatingSOPHiA GENETICS SA has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.33, SOPHiA GENETICS SA has an estimated upside of 57.71% from its current price of $4.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $4.65.
Fair Value
-
According to the consensus of 4 analysts, SOPHiA GENETICS SA has 57.71% upside to fair value with a price target of $7.33 per share.
SOPH vs. S&P 500
-
Over the past 5 trading days, SOPHiA GENETICS SA has overperformed the S&P 500 by 1.25% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
SOPHiA GENETICS SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SOPHiA GENETICS SA has grown year-over-year revenues for 4 quarters straight. In the most recent quarter SOPHiA GENETICS SA reported revenues of $19.5M.
Earnings Growth
-
SOPHiA GENETICS SA earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter SOPHiA GENETICS SA reported earnings per share of -$0.30.
Enterprise value:
297.3M
EV / Invested capital:
2.40x
Price / LTM sales:
4.26x
EV / EBIT:
--
EV / Revenue:
4.06x
PEG ratio (5yr expected):
-1.57x
EV / Free cash flow:
-6.05x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$49.5M
Return On Assets:
-45.62%
Net Income Margin (TTM):
-102.29%
Return On Equity:
-86.58%
Return On Invested Capital:
-57.5%
Operating Margin:
-88.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $58.7M | $64.5M | $73.3M | $15.9M | $19.5M | |
| Gross Profit | $40.6M | $43.7M | $49.5M | $10.7M | $12.9M | |
| Operating Income | -$72M | -$68.3M | -$69.4M | -$15.4M | -$17.3M | |
| EBITDA | -$64.1M | -$60M | -$60.1M | -$13.2M | -$14.9M | |
| Diluted EPS | -$1.07 | -$1.09 | -$1.12 | -$0.28 | -$0.30 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $300.8M | $208M | $153.1M | $117.2M | $103.5M | |
| Total Assets | $334.9M | $250.6M | $205.9M | $177.6M | $163.5M | |
| Current Liabilities | $27.8M | $28M | $28.9M | $30.9M | $36.9M | |
| Total Liabilities | $45.2M | $44.7M | $47.4M | $64.1M | $102.8M | |
| Total Equity | $289.7M | $205.9M | $158.4M | $113.5M | $60.7M | |
| Total Debt | $13M | $16.3M | $17.9M | $31.7M | $63.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$49M | -$43.7M | -$40.8M | -$9.3M | -$10.4M | |
| Cash From Investing | $23.1M | -$8.7M | -$8.9M | -$2.5M | -$3.4M | |
| Cash From Financing | -$3M | $11.9M | $34.3M | -$191.4K | -$205.2K | |
| Free Cash Flow | -$59.4M | -$52.3M | -$49.2M | -$11.8M | -$13.2M | |
SOPH
Sector
Market Cap
$315.5M
$27.9M
Price % of 52-Week High
87.74%
50.56%
Dividend Yield
0%
0%
Shareholder Yield
-2.14%
-1.55%
1-Year Price Total Return
38.39%
-17.49%
Beta (5-Year)
--
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.68
200-day SMA
Buy
Level
$3.62
Bollinger Bands (100)
Buy
Level
3.5 - 4.74
Chaikin Money Flow
Sell
Level
-15.9K
20-day SMA
Sell
Level
$4.76
Relative Strength Index (RSI14)
Sell
Level
49.49
ADX Line
Sell
Level
6.06
Williams %R
Neutral
Level
-66.5179
50-day SMA
Buy
Level
$4.58
MACD (12, 26)
Buy
Level
1.30
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Sell
Level
-42.6K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.3408)
Sell
CA Score
(Annual)
Level (-1.1584)
Buy
Beneish M-Score
(Annual)
Level (-3.4341)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (2.6548)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
Stock Forecast FAQ
In the current month, SOPH has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SOPH average analyst price target in the past 3 months is $7.33.
-
Where Will SOPHiA GENETICS SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that SOPHiA GENETICS SA share price will rise to $7.33 per share over the next 12 months.
-
What Do Analysts Say About SOPHiA GENETICS SA?
Analysts are divided on their view about SOPHiA GENETICS SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SOPHiA GENETICS SA is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is SOPHiA GENETICS SA's Price Target?
The price target for SOPHiA GENETICS SA over the next 1-year time period is forecast to be $7.33 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SOPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SOPHiA GENETICS SA is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SOPH?
You can purchase shares of SOPHiA GENETICS SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SOPHiA GENETICS SA shares.
-
What Is The SOPHiA GENETICS SA Share Price Today?
SOPHiA GENETICS SA was last trading at $4.65 per share. This represents the most recent stock quote for SOPHiA GENETICS SA. Yesterday, SOPHiA GENETICS SA closed at $4.65 per share.
-
How To Buy SOPHiA GENETICS SA Stock Online?
In order to purchase SOPHiA GENETICS SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SOPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SOPH
Sector
P/E ratio
--
23.75x
PEG ratio
-1.57x
-0.01x
P/B ratio
5.20x
1.81x
Price / LTM sales
4.26x
1.59x
Growth Metrics
SOPH
Sector
Revenue growth
22.77%
4.6%
Earnings growth
-6.37%
10.88%
Revenue (5-year growth)
20.78%
6.45%
Earnings forecast
-$0.20
-$0.21
Profitability
SOPH
Sector
Profitability FY 2024
$38.9M
$3.6M
Return on invested capital
-57.5%
-31.84%
Return on assets
-45.62%
-27.96%
Return on equity
-86.58%
-37.63%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
3
Balance Sheet
SOPH
Sector
Total cash
$81.6M
$26.3M
Short term investments
--
$25.7M
Total assets
$156.4M
$76.9M
Long term debt
$63.4M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 36.69% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 1.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 4.26% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
